Restless Legs Syndrome and Mortality in Kidney Transplant Recipients

M. Molnár, A. Szentkirályi, Anett Lindner, Maria Eszter Czira, L. Szeifert, A. Kovács, Katalin Fornadi, Andras Szabo, L. Rosivall, I. Mucsi, M. Novák

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: Previous studies showed an association between the presence of restless legs syndrome (RLS) and mortality in patients on dialysis therapy. An association between RLS and cardiovascular risk also was reported in the general population. However, no prospective study to date assessed the association between the presence of RLS and mortality in kidney transplant recipients. In a prospective cohort study (Transplantation and Quality of Life-Hungary Study), we tested the hypothesis that the presence of RLS predicts mortality in transplant recipients. Study Design: Prospective cohort study was performed. Settings & Participants: 804 kidney transplant recipients followed up at a single outpatient transplant center were enrolled in the study. Sociodemographic parameters, laboratory data, and medical history were collected at baseline. Data for 4-year outcomes were collected prospectively from patient charts. Predictor: Presence of RLS assessed using the RLS Questionnaire. Outcome & Measurements: We defined 3 primary outcomes: mortality with functioning graft, return to dialysis therapy, and the combined outcome of these 2. Results: Mean age was 49 ± 13 years, estimated glomerular filtration rate was 49 ± 19 mL/min/1.73 m2, and median time after transplantation was 54 months. During the 4 years, 97 patients died and 63 patients returned to dialysis therapy. Mortality at 4 years was significantly greater in patients who had RLS at baseline: univariate hazard ratio for the presence of RLS was 2.53 (95% confidence interval, 1.31 to 4.87). In multivariate Cox proportional hazard analysis, the presence of RLS significantly predicted mortality (hazard ratio, 2.02; 95% confidence interval, 1.03 to 3.95) after adjustment for several covariables. Limitations: The RLS Questionnaire was not validated in transplant recipients. We lacked information for key variables, including HLA mismatch, panel reactive antibodies, cold ischemic time, acute rejection episodes, viral infections, smoking status, and dyslipidemia. Conclusions: RLS, a potentially treatable disease, is a significant risk factor for mortality in kidney transplant recipients.

Original languageEnglish
Pages (from-to)813-820
Number of pages8
JournalAmerican Journal of Kidney Diseases
Volume50
Issue number5
DOIs
Publication statusPublished - Nov 2007

Fingerprint

Restless Legs Syndrome
Kidney
Mortality
Dialysis
Prospective Studies
Transplant Recipients
Cohort Studies
Transplantation
Confidence Intervals
Transplants
Cold Ischemia
Hungary
Virus Diseases
Dyslipidemias
Glomerular Filtration Rate
Outpatients
Therapeutics
Smoking
Quality of Life

Keywords

  • kidney transplantation
  • mortality
  • Restless legs syndrome
  • transplant outcomes

ASJC Scopus subject areas

  • Nephrology

Cite this

Restless Legs Syndrome and Mortality in Kidney Transplant Recipients. / Molnár, M.; Szentkirályi, A.; Lindner, Anett; Czira, Maria Eszter; Szeifert, L.; Kovács, A.; Fornadi, Katalin; Szabo, Andras; Rosivall, L.; Mucsi, I.; Novák, M.

In: American Journal of Kidney Diseases, Vol. 50, No. 5, 11.2007, p. 813-820.

Research output: Contribution to journalArticle

@article{f9d041186c7e4212beccbc45b6c7366f,
title = "Restless Legs Syndrome and Mortality in Kidney Transplant Recipients",
abstract = "Background: Previous studies showed an association between the presence of restless legs syndrome (RLS) and mortality in patients on dialysis therapy. An association between RLS and cardiovascular risk also was reported in the general population. However, no prospective study to date assessed the association between the presence of RLS and mortality in kidney transplant recipients. In a prospective cohort study (Transplantation and Quality of Life-Hungary Study), we tested the hypothesis that the presence of RLS predicts mortality in transplant recipients. Study Design: Prospective cohort study was performed. Settings & Participants: 804 kidney transplant recipients followed up at a single outpatient transplant center were enrolled in the study. Sociodemographic parameters, laboratory data, and medical history were collected at baseline. Data for 4-year outcomes were collected prospectively from patient charts. Predictor: Presence of RLS assessed using the RLS Questionnaire. Outcome & Measurements: We defined 3 primary outcomes: mortality with functioning graft, return to dialysis therapy, and the combined outcome of these 2. Results: Mean age was 49 ± 13 years, estimated glomerular filtration rate was 49 ± 19 mL/min/1.73 m2, and median time after transplantation was 54 months. During the 4 years, 97 patients died and 63 patients returned to dialysis therapy. Mortality at 4 years was significantly greater in patients who had RLS at baseline: univariate hazard ratio for the presence of RLS was 2.53 (95{\%} confidence interval, 1.31 to 4.87). In multivariate Cox proportional hazard analysis, the presence of RLS significantly predicted mortality (hazard ratio, 2.02; 95{\%} confidence interval, 1.03 to 3.95) after adjustment for several covariables. Limitations: The RLS Questionnaire was not validated in transplant recipients. We lacked information for key variables, including HLA mismatch, panel reactive antibodies, cold ischemic time, acute rejection episodes, viral infections, smoking status, and dyslipidemia. Conclusions: RLS, a potentially treatable disease, is a significant risk factor for mortality in kidney transplant recipients.",
keywords = "kidney transplantation, mortality, Restless legs syndrome, transplant outcomes",
author = "M. Moln{\'a}r and A. Szentkir{\'a}lyi and Anett Lindner and Czira, {Maria Eszter} and L. Szeifert and A. Kov{\'a}cs and Katalin Fornadi and Andras Szabo and L. Rosivall and I. Mucsi and M. Nov{\'a}k",
year = "2007",
month = "11",
doi = "10.1053/j.ajkd.2007.08.003",
language = "English",
volume = "50",
pages = "813--820",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Restless Legs Syndrome and Mortality in Kidney Transplant Recipients

AU - Molnár, M.

AU - Szentkirályi, A.

AU - Lindner, Anett

AU - Czira, Maria Eszter

AU - Szeifert, L.

AU - Kovács, A.

AU - Fornadi, Katalin

AU - Szabo, Andras

AU - Rosivall, L.

AU - Mucsi, I.

AU - Novák, M.

PY - 2007/11

Y1 - 2007/11

N2 - Background: Previous studies showed an association between the presence of restless legs syndrome (RLS) and mortality in patients on dialysis therapy. An association between RLS and cardiovascular risk also was reported in the general population. However, no prospective study to date assessed the association between the presence of RLS and mortality in kidney transplant recipients. In a prospective cohort study (Transplantation and Quality of Life-Hungary Study), we tested the hypothesis that the presence of RLS predicts mortality in transplant recipients. Study Design: Prospective cohort study was performed. Settings & Participants: 804 kidney transplant recipients followed up at a single outpatient transplant center were enrolled in the study. Sociodemographic parameters, laboratory data, and medical history were collected at baseline. Data for 4-year outcomes were collected prospectively from patient charts. Predictor: Presence of RLS assessed using the RLS Questionnaire. Outcome & Measurements: We defined 3 primary outcomes: mortality with functioning graft, return to dialysis therapy, and the combined outcome of these 2. Results: Mean age was 49 ± 13 years, estimated glomerular filtration rate was 49 ± 19 mL/min/1.73 m2, and median time after transplantation was 54 months. During the 4 years, 97 patients died and 63 patients returned to dialysis therapy. Mortality at 4 years was significantly greater in patients who had RLS at baseline: univariate hazard ratio for the presence of RLS was 2.53 (95% confidence interval, 1.31 to 4.87). In multivariate Cox proportional hazard analysis, the presence of RLS significantly predicted mortality (hazard ratio, 2.02; 95% confidence interval, 1.03 to 3.95) after adjustment for several covariables. Limitations: The RLS Questionnaire was not validated in transplant recipients. We lacked information for key variables, including HLA mismatch, panel reactive antibodies, cold ischemic time, acute rejection episodes, viral infections, smoking status, and dyslipidemia. Conclusions: RLS, a potentially treatable disease, is a significant risk factor for mortality in kidney transplant recipients.

AB - Background: Previous studies showed an association between the presence of restless legs syndrome (RLS) and mortality in patients on dialysis therapy. An association between RLS and cardiovascular risk also was reported in the general population. However, no prospective study to date assessed the association between the presence of RLS and mortality in kidney transplant recipients. In a prospective cohort study (Transplantation and Quality of Life-Hungary Study), we tested the hypothesis that the presence of RLS predicts mortality in transplant recipients. Study Design: Prospective cohort study was performed. Settings & Participants: 804 kidney transplant recipients followed up at a single outpatient transplant center were enrolled in the study. Sociodemographic parameters, laboratory data, and medical history were collected at baseline. Data for 4-year outcomes were collected prospectively from patient charts. Predictor: Presence of RLS assessed using the RLS Questionnaire. Outcome & Measurements: We defined 3 primary outcomes: mortality with functioning graft, return to dialysis therapy, and the combined outcome of these 2. Results: Mean age was 49 ± 13 years, estimated glomerular filtration rate was 49 ± 19 mL/min/1.73 m2, and median time after transplantation was 54 months. During the 4 years, 97 patients died and 63 patients returned to dialysis therapy. Mortality at 4 years was significantly greater in patients who had RLS at baseline: univariate hazard ratio for the presence of RLS was 2.53 (95% confidence interval, 1.31 to 4.87). In multivariate Cox proportional hazard analysis, the presence of RLS significantly predicted mortality (hazard ratio, 2.02; 95% confidence interval, 1.03 to 3.95) after adjustment for several covariables. Limitations: The RLS Questionnaire was not validated in transplant recipients. We lacked information for key variables, including HLA mismatch, panel reactive antibodies, cold ischemic time, acute rejection episodes, viral infections, smoking status, and dyslipidemia. Conclusions: RLS, a potentially treatable disease, is a significant risk factor for mortality in kidney transplant recipients.

KW - kidney transplantation

KW - mortality

KW - Restless legs syndrome

KW - transplant outcomes

UR - http://www.scopus.com/inward/record.url?scp=35348847076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348847076&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2007.08.003

DO - 10.1053/j.ajkd.2007.08.003

M3 - Article

VL - 50

SP - 813

EP - 820

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 5

ER -